Skip to content

Clinical trials

Phase 2 Conjunctivitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Conjunctivitis Phase: Phase 2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20095
20121
20132
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research3
ALK-Abelló A/S2
NovaBay Pharmaceuticals, Inc.2
Invirsa, Inc.1
Koffler Vision Group1
Marinomed Biotech AG1
National Eye Institute (NEI)1
Regeneron Pharmaceuticals1
Sacsh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Conjunctivitis13
Conjunctivitis, Allergic4
Hypersensitivity2
Rhinitis2
Rhinitis, Allergic2
Adenoviridae Infections1
Asthma1
Conjunctivitis, Bacterial1
Corneal Diseases1
Corneal Ulcer1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.